Differential gene expression and network analysis suggested biological determinants of immune response
PD
To identify molecular pathways associated with atezolizumab activity, we performed differential gene expression (DGE) analysis comparing patients experiencing partial response (PR)/SD and PD. DGE pathway analysis using the Hallmark gene sets revealed immune-related pathways upregulated in patients with PR/SD (Fig. 